Home > Journals > Minerva Endocrinology > Past Issues > Minerva Endocrinology 2022 September;47(3) > Minerva Endocrinology 2022 September;47(3):261-3

CURRENT ISSUE
 

JOURNAL TOOLS

Publishing options
eTOC
To subscribe PROMO
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as
Share

 

EDITORIAL   Free accessfree

Minerva Endocrinology 2022 September;47(3):261-3

DOI: 10.23736/S2724-6507.22.03879-9

Copyright © 2022 EDIZIONI MINERVA MEDICA

language: English

Targeting receptor tyrosine kinases in neuroendocrine neoplasm: what’s going on with lung carcinoids?

Alessandra DICITORE 1 , Maria C. CANTONE 2

1 Department of Medical Biotechnology and Translational Medicine (BIOMETRA), University of Milan, Milan, Italy; 2 Laboratory of Geriatric and Oncologic Neuroendocrinology Research, Istituto Auxologico Italiano IRCCS, Cusano Milanino, Milan, Italy



top of page